Perceval valve; aortic valve; aortic valve replacement; sutureless aortic valve replacement; Surgery; Pulmonary and Respiratory Medicine; Cardiology and Cardiovascular Medicine
Abstract :
[en] [en] OBJECTIVE: The aim of this study was to evaluate the outcome and experience of the Perceval sutureless valve at our institution (UZ Leuven).
METHODS: Between 2007 and 2019, 784 patients underwent sutureless aortic valve replacement using the Perceval valve (isolated or combined with other procedures). We performed a retrospective analysis of the postoperative and follow-up data.
RESULTS: Mean age was 78 years with a median European System for Cardiac Operative Risk Evaluation II score of 4.2% (interquartile range, 2.6%-7.2%). Isolated aortic valve replacement accounted for 45% of cases; 30% of cases were aortic valve replacement in combination with coronary artery bypass grafting and the remaining 25% were other combined procedures. The median crossclamp times were 38 minutes in single aortic valve replacement, 70 minutes in cases with coronary artery bypass grafting, and 89 minutes in multiple valve cases. Device success was 99.1% and in-hospital mortality was 3.3%. Postoperative stroke or transient ischemic attack occurred in 1.9% of patients and 1% of patients had a new need for dialysis after surgery and median survival time was 7.0 years with a cumulative follow-up of 2797.8 patient-years. The 1-, 5-, and 10-year freedom from reintervention were 99%, 97%, and 94%, respectively.
CONCLUSIONS: These data represent the longest follow-up available, to our knowledge, for the Perceval sutureless valve. We observed favorable early outcomes, and low rates of early mortality, stroke, and other major complications. Valve durability is promising with low rates of valve degeneration and a limited need for reintervention.
Disciplines :
Surgery
Author, co-author :
Lamberigts, Marie; Department of Cardiac Surgery, UZ Leuven, Leuven, Belgium. Electronic address: marie.lamberigts@kuleuven.be
Szecel, Delphine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de chirurgie cardio-vasculaire et thoracique ; Department of Cardiac Surgery, UZ Leuven, Leuven, Belgium
Rega, Filip; Department of Cardiac Surgery, UZ Leuven, Leuven, Belgium
Verbrugghe, Peter; Department of Cardiac Surgery, UZ Leuven, Leuven, Belgium
Dubois, Christophe; Department of Cardiology, UZ Leuven, Leuven, Belgium
Meuris, Bart; Department of Cardiac Surgery, UZ Leuven, Leuven, Belgium
Language :
English
Title :
Sutureless aortic valves in isolated and combined procedures: Thirteen years of experience in 784 patients.
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 60 (2021), 727–800.
Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P. III, Gentile, F., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 143 (2021), e72–e227.
Rubino, A.S., Santarpino, G., De Praetere, H., Kasama, K., Dalen, M., Sartipy, U., et al. Early and intermediate outcome after aortic valve replacement with a sutureless bioprosthesis: results of a multicenter study. J Thorac Cardiovasc Surg 148 (2014), 865–871 discussion: 71.
D'Onofrio, A., Messina, A., Lorusso, R., Alfieri, O.R., Fusari, M., Rubino, P., et al. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the “gray zone” between transcatheter aortic valve implantation and conventional surgery: a propensity-matched, multicenter analysis. J Thorac Cardiovasc Surg 144 (2012), 1010–1016.
Miceli, A., Santarpino, G., Pfeiffer, S., Murzi, M., Gilmanov, D., Concistre, G., et al. Minimally invasive aortic valve replacement with Perceval S sutureless valve: early outcomes and one-year survival from two European centers. J Thorac Cardiovasc Surg 148 (2014), 2838–2843.
Szecel, D., Eurlings, R., Rega, F., Verbrugghe, P., Meuris, B., Perceval sutureless aortic valve implantation: mid-term outcomes. Ann Thorac Surg 111 (2021), 1331–1337.
Glauber, M., Di Bacco, L., Cuenca, J., Di Bartolomeo, R., Baghai, M., Zakova, D., et al. Minimally invasive aortic valve replacement with sutureless valves: results from an international prospective registry. Innovations (Phila) 15 (2020), 120–130.
Vogt, F., Pfeiffer, S., Dell'Aquila, A.M., Fischlein, T., Santarpino, G., Sutureless aortic valve replacement with Perceval bioprosthesis: are there predicting factors for postoperative pacemaker implantation?. Interact Cardiovasc Thorac Surg 22 (2016), 253–258.
Cerillo, A.G., Amoretti, F., Mariani, M., Cigala, E., Murzi, M., Gasbarri, T., et al. Increased gradients after aortic valve replacement with the Perceval valve: the role of oversizing. Ann Thorac Surg 106 (2018), 121–128.
Geršak, B., Glauber, M., Bouchard, D., Jug, J., Solinas, M., Oversizing increases pacemaker implantation rate after sutureless minimally invasive aortic valve replacement. Innovations (Phila) 15 (2020), 449–455.
Fabre, O., Radutoiu, M., Carjaliu, I., Rebet, O., Gautier, L., Hysi, I., Recent improvement in operative techniques lead to lower pacemaker rate after Perceval implant. Interact Cardiovasc Thorac Surg, 35, 2022, ivac182.
Szecel, D., Lamberigts, M., Rega, F., Verbrugghe, P., Dubois, C., Meuris, B., Avoiding oversizing in sutureless valves leads to lower transvalvular gradients and less permanent pacemaker implants postoperatively. Interact Cardiovasc Thorac Surg, 35, 2022, ivac157.
Kappetein, A.P., Head, S.J., Généreux, P., Piazza, N., van Mieghem, N.M., Blackstone, E.H., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg 42 (2012), S45–S60.
Capodanno, D., Petronio, A.S., Prendergast, B., Eltchaninoff, H., Vahanian, A., Modine, T., et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38 (2017), 3382–3390.
Therneau, T.M., A package for survival analysis in R. https://CRAN.R-project.org/package=survival. (Accessed 1 June 2022)
Mack, M.J., Leon, M.B., Thourani, V.H., Makkar, R., Kodali, S.K., Russo, M., et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380 (2019), 1695–1705.
Shinn, S.H., Altarabsheh, S.E., Deo, S.V., Sabik, J.H., Markowitz, A.H., Park, S.J., A systemic review and meta-analysis of sutureless aortic valve replacement versus transcatheter aortic valve implantation. Ann Thorac Surg 106 (2018), 924–929.
Popma, J.J., Deeb, G.M., Yakubov, S.J., Mumtaz, M., Gada, H., O'Hair, D., et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380 (2019), 1706–1715.
Chiariello, G.A., Villa, E., Messina, A., Dalla Tomba, M., Cirillo, M., Brunelli, F., et al. Perceval valve-in-valve implant for full root xenograft failure. J Card Surg 32 (2017), 567–570.
Fischlein, T., Meuris, B., Hakim-Meibodi, K., Misfeld, M., Carrel, T., Zembala, M., et al. The sutureless aortic valve at 1 year: a large multicenter cohort study. J Thorac Cardiovasc Surg 151 (2016), 1617–1626.e4.
Shrestha, M., Fischlein, T., Meuris, B., Flameng, W., Carrel, T., Madonna, F., et al. European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients. Eur J Cardiothorac Surg 49 (2016), 234–241.
Laborde, F., Fischlein, T., Hakim-Meibodi, K., Misfeld, M., Carrel, T., Zembala, M., et al. Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg 49 (2016), 978–986.
Bowdish, M.E., D'Agostino, R.S., Thourani, V.H., Schwann, T.A., Krohn, C., Desai, N., et al. STS Adult Cardiac Surgery Database: 2021 update on outcomes, quality, and research. Ann Thorac Surg 111 (2021), 1770–1780.
Kim, D.J., Lee, S., Joo, H.C., Youn, Y.N., Yoo, K.J., Lee, S.H., Clinical and hemodynamic outcomes in 121 patients who underwent Perceval sutureless aortic valve implantation-early results from a single Korean institution. Circ J 85 (2021), 1011–1017.
Concistrè, G., Chiaramonti, F., Bianchi, G., Cerillo, A., Murzi, M., Margaryan, R., et al. Aortic valve replacement with Perceval bioprosthesis: single-center experience with 617 implants. Ann Thorac Surg 105 (2018), 40–46.
Pfeiffer, S., Sirch, J., Vogt, F., Fischlein, T., Santarpino, G., Implantation of the Sorin Perceval(R) sutureless aortic valve: a step by step approach. Minerva Cardioangiol 65 (2017), 184–192.
Ellouze, M., Mazine, A., Carrier, M., Bouchard, D., Sutureless and transcatheter aortic valve replacement: when rivals become allies. Semin Thorac Cardiovasc Surg 32 (2020), 427–430.
